liraglutide to semaglutide conversion Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are The conversion of long-acting glimepiride

Clinical trials have shown that patients can achieve substantial weight loss, often in the range of 10-15% of their body weight over 68 weeks, which is significant compared to other options available

Step 2: Complete the medical intake - Provide detailed information about health history, current medications, goals, and lifestyle

[1] [2] Missing a scheduled dose is a common occurrence, and the appropriate response depends on how much time has elapsed since your missed injection

Check which tier the drug is in, as this dictates your copay

Heres a closer look at what people frequently ask aboutand what may help if you notice these changes: Being aware of these potential side effects can help you feel more prepared